Iopamidol

CAS 60166-93-0 7 current records 4 historicalSmall Molecule

Who holds supplier records for Iopamidol? 7 organisations hold a current record for Iopamidol: an active US FDA Type II Drug Master File or a CEP. A further 4 organisations have only historical (inactive) DMF filings. 5 of them hold a valid EU Certificate of Suitability (6 holder entries on the EDQM register, listed below). Recorded organisation countries for current records: China (3), India (1), Italy (1) and South Korea (1); not recorded for 1.

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Iopamidol: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/iopamidol

Reading the evidence

  • 7 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • 2 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (7)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Iopamidol. Country is the organisation's recorded country, not necessarily the manufacturing site.

China3India1Italy1South Korea1Country not recorded for 1
  • Zhejiang Starry Pharmaceutical Co., Ltd
    Active DMF 36683, 28033 · latest filing Jan 2022
    ChinaCEP
  • Divis Laboratories
    Active DMF 18066 · latest filing Feb 2005
    IndiaCEP Company GMP cert on record
  • Bracco Imaging S.p.A.
    Active DMF 10638 · latest filing Dec 1993
    Italy Company GMP cert on record
  • SUZHOU RYWAY BIOTECH CO LTD
    Active DMF 42386 · latest filing Aug 2025
  • DONGKOOK LIFE SCIENCE CO. LTD.
    Valid CEP holder (EDQM); not necessarily the manufacturer
    South KoreaCEP
  • ZHEJIANG TAIZHOU HISYN PHARMACEUTICAL CO., LTD.
    Valid CEP holder (EDQM); not necessarily the manufacturer
    ChinaCEP
  • JIANGXI BROTHER PHARMACEUTICAL CO., LTD.
    Valid CEP holder (EDQM); not necessarily the manufacturer
    ChinaCEP
Need Iopamidol sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (6)

Certificates of Suitability on the EDQM register for Iopamidol, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 10 certificates in total, including withdrawn, expired, suspended and repeat certificates.

HolderCountryCertificateIssuedEU GMP at holder's address
DONGKOOK LIFE SCIENCE CO. LTD. Gyeonggi-doKR
CEP 2023-300 - Rev 00
Iopamidol
Apr 2026—
ZHEJIANG TAIZHOU HISYN PHARMACEUTICAL CO., LTD. LinhaiCN
CEP 2025-334 - Rev 00
Iopamidol, Product C02
Sept 2025—
JIANGXI BROTHER PHARMACEUTICAL CO., LTD. Jiujiang CityCN
CEP 2022-502 - Rev 00
Iopamidol
May 2024—
ZHEJIANG STARRY PHARMACEUTICAL CO., LTD. XianjuCN
R0-CEP 2022-050 - Rev 01
Iopamidol, Process 2
Aug 2023—
DONGKOOK LIFE SCIENCE CO. LTD. SeoulKR
R1-CEP 1999-090 - Rev 03
Iopamidol
Nov 2022—
DIVI'S LABORATORIES LIMITED HyderabadIN
R1-CEP 2006-038 - Rev 04
Iopamidol
Dec 2018—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (4)

Organisations whose Type II DMFs for Iopamidol are no longer active. These show a past filing, not current supply.

Show all 4 historical records
  • ABBOTT LABORATORIES CHEMICAL AND AGRICULTURAL PRODUCTS DIV
    Inactive DMF 12442 · filed Mar 1997
  • Italy · Inactive DMF 12211 · filed Nov 1996
  • HOVIONE SOCIEDADE QUIMICA SA
    Inactive DMF 11245 · filed Dec 1994
  • ZAMBON GROUP SPA
    Inactive DMF 10564 · filed Oct 1993

US product patents and exclusivity

The FDA Orange Book lists patents and exclusivities for specific approved products (15 listed products contain Iopamidol). The latest listed exclusivity runs to 10 Oct 2028. These dates are product-specific: they can cover a formulation, a combination or a method of use, and do not on their own show whether the ingredient is protected or whether generics are already approved. Check the individual product entries before planning a launch.

Overview

Iopamidol is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL1200932).

Chemical identity

IUPAC name
1-N,3-N-bis(1,3-dihydroxypropan-2-yl)-5-[[(2S)-2-hydroxypropanoyl]amino]-2,4,6-triiodobenzene-1,3-dicarboxamide
Canonical SMILES
C[C@@H](C(=O)NC1=C(C(=C(C(=C1I)C(=O)NC(CO)CO)I)C(=O)NC(CO)CO)I)O
InChIKey
XQZXYNRDCRIARQ-LURJTMIESA-N
Synonyms
Iopamidol, Iopamidol-200, Iopamidol-250, Iopamidol-300, Iopamidol-370, Iopamiron, Isovue, Isovue-128, Isovue-200, Isovue-250, Isovue-300, Isovue-370

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Radiographic Contrast Agent
Mechanism of action
X-Ray Contrast Activity

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Iopamidol?

7 organisations hold an active US FDA Type II Drug Master File or a CEP for Iopamidol: Zhejiang Starry Pharmaceutical Co., Ltd (China), Divis Laboratories (India), Bracco Imaging S.p.A. (Italy), SUZHOU RYWAY BIOTECH CO LTD, DONGKOOK LIFE SCIENCE CO. LTD. (South Korea), ZHEJIANG TAIZHOU HISYN PHARMACEUTICAL CO., LTD. (China) and JIANGXI BROTHER PHARMACEUTICAL CO., LTD. (China). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Iopamidol Drug Master Files are active?

Zhejiang Starry Pharmaceutical Co., Ltd (DMF 36683, 28033), Divis Laboratories (DMF 18066), Bracco Imaging S.p.A. (DMF 10638) and SUZHOU RYWAY BIOTECH CO LTD (DMF 42386). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Iopamidol records mean?

4 organisations have only inactive Type II DMFs for Iopamidol. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Iopamidol have a European Certificate of Suitability?

Yes. 5 organisations hold a valid CEP for Iopamidol on the EDQM register, including DONGKOOK LIFE SCIENCE CO. LTD. Gyeonggi-do (KR), ZHEJIANG TAIZHOU HISYN PHARMACEUTICAL CO., LTD. Linhai (CN), JIANGXI BROTHER PHARMACEUTICAL CO., LTD. Jiujiang City (CN), ZHEJIANG STARRY PHARMACEUTICAL CO., LTD. Xianju (CN), DONGKOOK LIFE SCIENCE CO. LTD. Seoul (KR) and DIVI'S LABORATORIES LIMITED Hyderabad (IN). A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

How do I qualify a Iopamidol supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Iopamidol?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.